Hereby, we demonstrate that both systemic and intracerebroventricular (ICV) administrations of SHLP2 protected the male mice from high-fat diet (HFD)-induced obesity and improved insulin sensitivity. The gene discussed is MT-RNR2; the disease is obesity due to melanocortin 4 receptor deficiency.